1Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase III study - Concepedia

Concepedia

Publication | Closed Access

1Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase III study

13

Citations

0

References

2021

Year

Rebecca Kristeleit, Alla Lisyanskaya, Alexander N. Fedenko, Mikhail Dvorkin, Andréia Cristina de Melo, Yaroslav Shparyk, Irina Rakhmatullina, Igor Bondarenko, Nicoletta Colombo, Valentyn Svintsitskiy,

Gynecologic Oncology

No additional data available for this publication yet. Check back later!